COIOSDeep risk insights through multi-disciplinary research across the globe
People stroll along a boardwalk by the water
Item new Preprint · not peer-reviewed Added

Tuberculosis vaccine VPM1002 is modelled as stronger against disease outside the lungs

A dynamic model of tuberculosis in India estimated the VPM1002 vaccine to be 42.9% effective against disease outside the lungs and 14.0% against lung disease, both intervals including no effect.

A deterministic transmission model of tuberculosis in India, calibrated to WHO data for 2015 to 2024, evaluated three doses of VPM1002 ten years apart. Estimated effectiveness was 42.9% against disease outside the lungs and 14.0% against lung disease, with both credible intervals including no effect. Per million people targeted, three doses would avert 682 deaths at US$329 per disability-adjusted life-year averted, assuming ten years of protection.

Why it is interesting: The modelled benefit rests on a trial signal whose credible interval still includes no effect.

Source
medRxiv, 2 October 2026
Paper
A disaggregated dynamic model of pulmonary and extrapulmonary tuberculosis for vaccine and booster-schedule evaluation: VPM1002 in India as a case study
Authors
Revathy M, Niranjan V, Uttarkar A, Swaminathan V, Carrese A, Bhargava A
DOI
10.64898/2026.07.31.26359434
Type
Preprint
Design
Deterministic dynamic transmission model, 1,152 compartments, calibrated to WHO India data 2015-2024, 1,000 Monte Carlo iterations
Verdict
New finding
Driver
Value in health
Driver
Infection and pandemics
Attention
1 citation (Crossref) · as of 2026-11-01

Other drivers in Data, models and systems